Stock & Company Details
Bio-Rad Laboratories Inc. $BIO
Price:
N/A
N/A
22M
$9.6B
52 Week High:
N/A
10 Day Average Volume:
N/A
43.69
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BIO technical indicators
Latest Bio-Rad Laboratories Inc. (BIO) indicator readings as of 2026-10-09.
BIO's 14-day RSI is 46.7, in neutral territory. At $366.16 it is trading 18.3% above its 200-day moving average of $309.39, and below its 50-day average of $370.19. Price sits in the middle of its Bollinger Bands ($359.05 to $390.10). ADX reads 26.6, indicating a trending market.
BIO backtested strategy results
How 4 rule-based strategies performed on Bio-Rad Laboratories Inc. (BIO) over recent history, last backtested 2026-10-08. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +20.3% | 43% | 14 | -58.1% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | -53.9% | 21% | 29 | -60.8% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -38.5% | 28% | 32 | -56.9% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | -2.6% | 65% | 20 | -36.6% |
Overview
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Finance Bot
Ask your questions
Start by typing a question below.
